Behavioral interventions to improve sleep outcomes in people with multiple sclerosis: A systematic review

David Turkowitch, Sarah J. Donkers, Silvana L. Costa, Prasanna Vaduvathiriyan, Joy Williams, Catherine Siengsukon
doi: https://doi.org/10.1101/2022.10.29.22281670

Abstract

Objective To determine effective behavioral interventions to improve sleep in people with MS.

Methods Systematic review following PRISMA guidelines.

Data Sources Literature searches were performed in December 2021 in Ovid MEDLINE, CINAHL, and Web of Science along with hand searching for grey literature and cited references. Out of the 837 search results, 830 unique references were reviewed after duplicates were removed.

Study Selection Four reviewers independently reviewed titles and abstracts (two reviewers for each article), and a fifth reviewer resolved discrepancies. The full-text articles (n = 81) were reviewed independently by four reviewers (two for each article) for eligibility, and consensus for inclusion was achieved by a fifth reviewer as needed. Thirty-seven articles were determined eligible for inclusion.

Data Extraction Four reviewers extracted relevant data from each study (two reviewers for each article) using a standard data-extraction table. Consensus was achieved for completeness and accuracy of the data extraction table by a fifth reviewer. Four reviewers (two reviewers for each article) conducted a quality appraisal of each article to assess the risk for bias and quality of the articles and consensus was achieved by a fifth reviewer as needed.

Data Synthesis Descriptions were used to describe types of interventions, sleep outcomes, results, and key components across interventions.

Conclusions The variability in the intervention types, intervention dose, outcomes used, training/expertise of interventionist, specific sample included, and quality of the study made it difficult to compare and synthesize results. Overall, the CBT-I, CBT/psychotherapy, and education/self-management support interventions reported positive improvements in sleep outcomes. The quality appraisal scores ranged from low to high quality indicating potential for bias. Further research is necessary to demonstrate efficacy of most of the interventions.

Nearly one million people in the US are living with multiple sclerosis (MS), and in this population, disturbed sleep is a very common challenge.1-3 Sleep problems are significantly more common in people with MS than in the general population, estimated at nearly 70% of individuals with MS.4,5 However, the incidence is likely higher as sleep disorders in individuals with MS are severely underdiagnosed.6,7

Common contributors of sleep disturbances in people with MS include nocturia, muscle spasticity, depression, anxiety, and pain.8-10 Furthermore, neuropathology due to MS may have direct physiological impact on the circadian rhythm,11,12 and side effects from medications can also have a significant effect on sleep, further complicating the treatment of sleep disturbances.9 Sleep disturbances in people with MS have been associated with poorer cognitive performance, lower quality of life, higher disability, and increased prevalence of pain, fatigue, depression, anxiety, and sexual and bladder dysfunction.13-18 Because of the overlapping symptoms of MS and disturbed sleep, poor sleep in people with MS is a complicated issue to treat.

Various pharmacological and lifestyle/behavioral interventions have been studied to address sleep disturbances in people with MS. Although pharmacological interventions are appropriate in certain cases, medication can have negative side effects (such as sedation, dizziness, cognitive impairment, and motor incoordination) and concerns for long-term use including exacerbation of sleep disturbances and insomnia.19-21 Conversely, behavioral interventions for the treatment of MS are safe for short and long-term use, have shown promising impact on sleep issues, may be more accessible, and may potentially modify the disease process.22 Behavioral interventions that have shown effective, durable, and safe results include cognitive behavioral therapy for insomnia (CBT-I), physical activity, mindfulness training, education, and psychotherapy. However, the effective components of sleep interventions in people with MS have yet to be summarized.

Accordingly, this systematic review focuses on the behavioral interventions being implemented to improve sleep in people with MS. The body of research examining behavioral interventions to improve sleep in people with MS is large and rapidly expanding; thus, the literature in the field has been assembled for close examination. The purpose of this systematic review is to determine effective behavioral interventions to improve sleep in people with MS. It is anticipated that this systematic review will act as a guide for clinical practice and future research in this burgeoning field by identifying efficacious behavioral interventions to enhance sleep as well as gaps in knowledge.

Methods

The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were used for identifying the standards of this review protocol. This systematic review was prospective registered at the International Prospective Register of Systematic Reviewers (PROSPERO; ID CRD42022302318). Ovid Medline, Embase.com, and Web of Science were used for identifying relevant studies. Both keywords and database provided controlled vocabularies are used in Embase and Ovid Medline databases along with various search techniques and Boolean operators. The Web of Science database was searched using keywords only. These terms included: multiple sclerosis, sleep, sleep wake disorders, circadian rhythm, exercise, exercise therapy, etc. (refer to supplementary file 1 for detailed search strategies). To include non-pharmaceutical intervention outcome of sleep quality, a wide variety of terms such as behavioral therapy, complementary therapy, mind body therapy, muscle relaxation, qigong, mindfulness, meditation, etc. were included in the search. Publication of language filters were not applied. Additional resources such as ClinialTrials.gov and Google scholar used for identifying relevant grey literature on the topic were also searched. Searches were performed between December 1st and 28th, 2021.

Studies were included in the systematic review if they: (1) involved the study of humans diagnosed with Multiple Sclerosis; (2) consisted of an intervention study design (i.e. pre-post test, randomized and non-randomized trial study design); (3) included lifestyle or behavioral interventions; and (4) included sleep as an outcome. Studies were excluded from the systematic review if they: (1) included the study of animals; (2) involved any other neurologic condition; (3) were written in a non-English language; (4) involved irrelevance to objectives; (5) included non-intervention study design (reviews, opinions, editorials, protocols, cross-sectional, observational); and (6) contained a duplicate data set (same data reported in more than one study).

Each title/abstract was independently reviewed by two of the four reviewers (S.L.C., S.J.D., C.S., and D.T) and determined as eligible or ineligible based on the above inclusion/exclusion criteria). Discrepancies were resolved by a fifth reviewer (J.W.) in order to reach consensus. The same four reviewers then reviewed the full-text manuscripts for eligibility, and consensus was reached on discrepancies by the fifth reviewer.

Data was then extracted from the full-text articles by both a primary reviewer and a secondary reviewer (S.L.C., S.J.D., C.S., and D.T) using a standardized data extraction spreadsheet. Information extracted included the first author, publication year, country the study was conducted, study design, study objective, number of participants enrolled, number of dropouts, participant information including age, MS-type, severity, disease duration, specific impairment(s) for eligibility, intervention information including type, dose, interventionist, setting, study assessment timepoints, control group (if included), the primary and sleep outcome(s), and sleep-specific results. Consensus was reached on discrepancies by the fifth reviewer.

To assess the risk for potential bias and quality of the included articles, critical appraisals were independently conducted by four reviewers (two for each article; same reviewers who conducted data extraction), and discrepancies were resolved by the fifth reviewer. Five different quality appraisal tools were used according to article types: National Heart, Lung, and Blood Institute quality assessment for before-after (pre-post) studies with no control group,23 and Joanna Briggs Institute’s (JBI) critical appraisal checklists for randomized controlled trials (RCT), case reports, quasi-experimental studies, and qualitative research.24 Overall quality scores were then calculated for each study as follows: “yes” = 2, “unclear” and “cannot determine” = 1, and “not reported” or “no” = 0, and a percentage score was calculated.25 A score of 100% would indicate the highest possible quality score and demonstrate the quality in study design and implementation to reduce potential bias. Because the twelfth question was rated as “not applicable” for all the pre-post study design articles, the denominator was adjusted to eleven X 2 rather than twelve X 2 to calculate overall percent quality score. Also, two questions in the case series quality appraisal were deemed “not applicable” for the case series, so the denominator was adjusted to eight X 2 rather than ten X 2. In order to be consistent with other checklists, a “not reported” option to the JBI RCT checklist was added. Only one reviewer conducted quality appraisal for the qualitative research studies due to her being the sole reviewer with expertise in qualitative design. Also, since there is not a specific checklist for pilot RCTs, the JBI RCT appraisal checklist was used for studies that self-identified as a pilot RCT.

Results

The search strategy generated 1,269 total citations. There were 439 duplicates identified and removed, leaving 839 unique results. Subsequent title/abstract review excluded 749 studies, leaving 81 studies for full-text review. Following full text review, 44 studies were excluded, leaving 37 studies for data extraction and quality appraisal (Figure 1).

Figure 1.
Figure 1.

PRISMA flow diagram.

The studies that met the inclusion/exclusion criteria for this systematic review are summarized in Table 1 (organized by intervention type and by study design). Fifty one percent of the studies were conducted in North America (94% of which were in the United States), 29% in Europe, 23% in Asia, and 3% in Australia. The most prevalent study design was RCT (n=1926-35; 54%; of which n=936-44 self-identified as being a pilot RCT) followed by single group pre-post design (n=1145-55; 31%). Case reports (n=256,57; 6%), qualitative studies (n=258,59; 6%), quasi experimental studies (n=260,61; 6%), and case series (n=162; 3%), were also included. Four of the studies included are secondary analyses,27,58,59,63 two of which59,63 analyze data from a primary study also included in this systematic review.42,60

View this table:
Table 1.

Summary of articles. + = improvement in sleep; - = worsening, no improvement in sleep, or mixed results; ↗ = Improvement not statistically significant; FOSQ-10 = Functional Outcomes of Sleep Questionnaire; MCSB = Motivation to Change Sleep Behavior; SSES = Sleep Self-efficacy Scale; TST = total sleep time

Sample sizes ranged from one56,57 to 218 individuals29, and 1,565 individuals were included in total. Participants in all of the studies included were adults ranging in age from 34.3 years old26 to 60.1 years old.50 Relapse-remitting MS constituted the majority of MS types for every study except for three studies.39,51,57 Sleep was stated as the primary outcome in nine26,27,32,36,41,43,45,46,50 of the 37 studies. The Pittsburg Sleep Quality Index (PSQI) was the most commonly used sleep outcome utilized in 1926,29-31,35-39,41,42,44,48,50,53-55,57,60 of the studies followed by the Insomnia Severity Index (ISI) (n=1032-34,37,39,42,44,45,56,62), actigraphy (n=537,38,43,46,60), and sleep log/diary data (n=538,43,46,56,57); six of the studies incorporated an objective measurement (actigraphy (n=538,43,46,56,57); EEG (n=145)). Interventions included physical activity (n=1331-33,37-39,41,45,46,50,51,53,55), CBT-I (n=642-44,56,57,62), CBT/psychotherapy (n=426,27,30,), mindfulness/relaxation (n=628,48,49,58-60), education and self-management support (n=329,36,54,61), and complementary and alternative interventions including acupuncture47, neurofeedback and hypnosis64, trauma releasing exercises52, foot reflexology35, integrated imaginative distention34 (all n=1). Details regarding sample demographics, intervention provided, and the major sleep findings are summarized by intervention category in Table 2. Results of studies will next be summarized and described by intervention category.

View this table:
Table 2.

Details of study sample, intervention, and major sleep finding. 3M = 3 month reassessment; ACC = Active Control Condition; AE = Aquatic/Aerobic Exercise; BE = Basic Education; Bl = baseline; EDSS = Expanded Disease Status Scale; FTC = Fatigue: Take Control; HEP = Home Exercise Program; HYP = Hypnosis; IAYT = International Association of Yoga Therapists; ICRP= Integrated Cognitive Rehabilitation Program; MAE = Moderate-Intensity Aerobic Exercise Program; MBCT = Mindfulness Based Cognitive Therapy; MBSR = Mindfulness Based Stress Reduction; MDC = minimal detectable change; MCID = Minimal Clinically Important Difference; MFIS = Modified Fatigue Impact Scale; MM = Mindfulness Meditation; MSFC = Multiple Sclerosis Functional Composite; MSTC = Multiple Sclerosis: Take Control; NHS = National Health Service; PDDS = Patient Determined Disease Steps; PHQ-9 = Patient Health Questionnaire; PMRT = Progressive Muscle Relaxation Technique; PP = Primary Progressive [Multiple Sclerosis]; PT = Physical Therapist; RLS = Restless Legs Syndrome; RN = Rest Night; RR = Relapse-Remitting [Multiple Sclerosis]; SE = Sleep Efficiency; SEFT = Supportive Emotion-Focused Therapy; SLP = Speech-Language Pathologist; SP = Secondary Progressive [Multiple Sclerosis]; SSE = Sleep Self Efficacy; TAU = Treatment as Usual; TIB = Time in Bed; TN = Training Night; TRE = Trauma Releasing Exercises; TST = Total Sleep Time; WS = Walking and Stretching program.

Physical activity

Thirteen of the 37 included studies incorporated physical activity as a behavioral intervention.31-33,37-39,41,45,46,50,51,53,55 A variety of physical activity interventions were used including resistance training,46 aerobic exercise,32,37,41,45 general individualized exercise programs,39,50 physical activity lifestyle interventions,31,38,53 yoga,55 exoskeleton assisted walking,51 and aquatic exercise.33 Five of the physical activity studies stated sleep was a primary outcome.32,41,45,46,50 Of the five studies with sleep as the primary outcome, three were single group pre-post studies45,46,50, and two were RCTs65 (one being a self-identified pilot RCT41).

All four pilot physical activity RCTs had statistically significant improvement in sleep outcomes (effect size ranging from small to large).37-39,41 Siengsukon et al.41 was the only pilot physical activity RCT in which sleep was explicitly included the primary outcome. Siengsukon et al.41 reported that both the 12-week moderate-intensity aerobic exercise group and the low impact walking and stretching group experienced large significant improvements on the PSQI, but there was no significant between group difference; however, a significant between group difference was found on the Epworth Sleepiness Scale (ESS; large effect).

Cederberg & Motl38 reported on a sample of individuals with MS and restless legs syndrome. After 16 weeks of a physical activity intervention, they observed significant positive effects on the International Restless Legs Syndrome Study Group Scale (IRLS), restless legs syndrome (RLS) severity during the night and during the day while either resting and while active, sleep satisfaction, self-reported time in bed, and total sleep time following a physical activity intervention compared to the waitlist control. In addition, other sleep outcomes demonstrated moderate to large effect sizes although were not statistically significant.

Al-Sharman et al.37 reported that the six-week moderate-intensity aerobic exercise group had significant moderate-to-large improvements on the global PSQI, ISI, sleep efficiency, and wake time after sleep onset assessed via actigraphy compared to a home exercise group. Furthermore, change in serotonin was significantly correlated with change in PSQI within the aerobic exercise group.

Grubic-Kezele et al.39 reported a significant large improvement on the ISI following an eight-week individualized exercise program compared to socializing at the MS Society Center. The only PSQI measure that showed a significant large improvement was daytime sleep dysfunction. In addition, other sleep outcomes demonstrated small to large effect sizes although were not statistically significant.

Two of the RCTs reported medium effect sizes for ISI change following eight-week endurance training and coordinative training65 and eight-week, 2x/week aquatic exercise group.33 However, between group statistical comparisons were not provided in either study. In the third RCT study,31 there was a moderate non-significant improvement in PSQI in the intervention group that participated in a 24-week internet-delivered behavioral intervention to increase lifestyle physical activity, and there was no significant between group differences reported.

Three of the six single group pre-post study design physical activity studies stated sleep was a primary outcome. Jeong et al.50 reported a slight worsening of PSQI scores from baseline to 3 months of a daily individualized at-home exercise intervention. Sadeghi Bahmani et al.’s study45 on three weeks of endurance and physiotherapy sessions reported significantly improved ISI scores, sleep onset latency, sleep efficiency, and wake after sleep onset (WASO). Andreu-Caravaca et al.46 demonstrated improvements in sleep efficiency (via actigraphy) and sleep quality, comfort, feeling of rest, and ease of falling asleep (via Karolinska Sleep Diary) following resistance training sessions compared to non-training sessions.

In the other three single group pre-post study design physical activity studies, sleep was not the primary outcome or it was unclear if sleep was a primary outcome. Vasudevan et al.55 reported non-significant improvement on the PSQI using a 12-week personalized yoga program. Mehrebani et al.53 reported significant improvement in sleep quality immediately after a 15-week physical activity intervention; however, the improvement was not sustained seven weeks post-intervention. Kozlowski et al.’s51 eight-week study on exoskeleton assisted walking reported mix results using the Quality of Life in Neurological Conditions (NeuroQoL) sleep disturbance scale.

CBT-I

Six42-44,56,57,62 of the 37 total studies incorporated in this systematic review incorporated a CBT-I intervention, and all reported improved sleep outcomes. Three of these studies were pilot RCTs,42,44 one of which was a secondary analysis.43 Two of the CBT-I studies were case reports,56,57 and one was a case series.62 Sleep was stated as the primary outcome in only the secondary analysis.43

In Siengsukon et al.’s two pilot RCT studies, both the six-week web-based CBT-I44 and six week in-person CBT-I42 interventions produced significant large improvements in PSQI, ISI, and SSE scores. Secondary analysis by Williams-Cooke et al.43 of the in-person CBT-I study revealed sleep log data with significant moderate-to-large improvements in sleep efficacy and reduction in time in bed and variability in sleep efficacy. Actigraphy data from the CBT-I group demonstrated a significant large reduction in time in bed and total sleep time from baseline to post-intervention and the active control group showed a significant increase in variability in sleep efficiency.

Both individuals involved in the case reports demonstrated improved sleep outcomes. The case report by Loveless et al.56 included a mid-50 year old male with relapse remitting MS. After 13 total CBT-I sessions, the patient’s sleep log demonstrated an increase in sleep efficiency (from 29.0% to 74.49%) and total sleep time (from 2.69 to 5.86 hours) and decreases in sleep latency (from 145 to 60 minutes), wake after sleep onset (from 240 to 60 minutes), and early morning awakenings (from 110 min to 0 min). The case report by Majendie et al.57 included a 40-year-old male with secondary progressive MS and sleep disturbance. His global PSQI score improved from ten to five following eight sessions of CBT-I and was reported to be a one 7 months post-treatment. Sleep onset latency, sleep duration, and sleep efficiency also improved, and the participant implemented a medication withdrawal plan during his intervention time frame. In the case series by Clancy et al.62 most (86%) patients reported improvements in both ISI scores and total sleep time after an average of eight CBT-I sessions.

CBT/Psychotherapy

Three studies were included in the systematic review that incorporated CBT/psychotherapy without a mindfulness focus.26,27,30 Three were RCTs26,30, one of which was a secondary analysis27; two studies26,27 stated sleep was the primary outcome.

Kiropoulos et al.30 compared 8 weeks of CBT to treatment as usual and found group differences in PSQI scores both immediately post intervention and at 20 months follow up. Abbasi et al.26 reported significant differences in sleep quality between a group that received 8 sessions of CBT compared to a control group at both the post intervention and one month follow up timepoints. Baron et al.’s study27 was a secondary analysis of a study by Mohr et al.66 and reported a decline in reported insomnia from 78% as baseline to 43% at post treatment of telephone administered psychotherapy for depression.

Mindfulness and Relaxation

There were six studies that incorporated mindfulness and/or relaxation.48,49,58-60,67 None stated sleep as the primary outcome. One study was an RCT67, two were single group pre-post studies48,49, one was a quasi-experimental study60, and two were qualitative studies consisting of secondary analyses.58,59

Cavalera et al’s28 RCT reported a strong effect on the Medical Outcomes Study Sleep scale following an eight-week online mindfulness meditation intervention compared to an online psychoeducation control group at the post-intervention evaluation; however, there was no statistical difference between groups after 6 months.

Dayapoglu & Tan’s48 six-week single group pre-post progressive muscle relaxation study demonstrated global PSQI score improvement from pre to post intervention and significant improvement in the PSQI subscales of subjective sleep quality, sleep latency, sleep duration, sleep efficiency, sleep disorder, and daytime dysfunction. Hoogerwerf et al.’s49 single group pre-post study reported a small non-significant difference between pre, post, and 3-month Symptom Checklist-90 (SCL-90) scores following an eight-week mindfulness-based cognitive therapy intervention.

The intervention group in Lorenz et al.’s60 quasi-experimental study showed moderate to large pre-to-post effect on sleep behaviors (not significant), sleep efficiency (significant), and total sleep time (not significant) following an eight-week mindfulness-based stress reduction course study, although both the intervention and control groups had significantly reduced awakenings. There were no statistically significant differences between groups on sleep outcomes at post-intervention, however, there was a small non-significant effect on total sleep time and sleep behavior. Also, a one-way repeated measures ANOVA including baseline, post-intervention, three-month post-intervention for intervention group suggested a non-significant small-to medium effect on self-reported sleep quality and sleep behaviors. Sessanna et al.59 was a qualitative secondary analysis of the Lorenz et al. study60 and reported that the formats of the sleep retraining program were acceptable and provided an effective mode of delivery to adults with MS. Simpson et al.’s58 qualitative secondary analysis of an eight-week mindfulness-based stress reduction study68 found that improved sleep was commonly reported.

Education and Self-management Support

Four studies focused on MS education/fatigue management.29,36,54,61 One stated sleep was a primary outcome36. Two were RCTs29, one of which self-identified as a pilot RCT36, one utilized a single group pre-post study design,54 and one was a retrospective chart review.61

Hugos et al.’s29 RCT study compared two 6-week group programs: one was a multi component fatigue management program and the other was a MS education program (control). While there was no significant change in PSQI at program completion or at the 3-month follow-up in the fatigue management group, there was a significant improvement at the six-month follow-up in the fatigue management group compared to the control group; however, PSQI scores remained poor (> 5) at the six-month follow-up timepoint. Akbarfahimi et al.36 conducted a pilot RCT comparing an occupational therapy-based sleep intervention and care as usual as a control and found that sleep quality significantly improved in the intervention group compared to the control group.

Sauter et al.54 conducted a single group pre-post study assessing the impact of a fatigue management and reported the PSQI global score was significantly improved after the six-week course and remained improved after 7-9 months, and the sleep efficiency component score was also significantly improved at 7-9 months. Participants were initially divided into either a “treatment first” group or a “waitlist” then treatment group; however, all participants were included in the pre-post intervention statistical analyses. The retrospective study61 reported significant improvement in sleep disturbances following a 3-4 session individualized cognitive rehabilitation program; however, there was no between groups comparison conducted between the intervention group and the control group.

Complementary and Alternative Interventions

Five studies utilized complementary or alternative interventions to address sleep issues, including acupuncture,47 neurofeedback and mindfulness used in conjunction with hypnosis,64 trauma releasing exercises,52 foot reflexology,35 and integrated imaginative distention.34 None included sleep as the primary outcome. Three were RCTs,34,35 one of which self-identified as a pilot RCT,64 and two utilized a single group pre-post study design.47,52

Sajadi et al.’s69 RCT reported a significant difference in sleep quality between the group that participated in foot reflexology and the placebo group following the intervention; however, the intervention group’s average PSQI score was significantly worse than the control group’s PSQI score at baseline. Sgoifo et al.’s34 RCT reported no significant difference in ISI change scores between the integrative imaginative distention intervention group and the waitlist control group. In Jensen et al.’s pilot RCT,64 participants received an intervention with neurofeedback and hypnosis (NF-HYP), mindfulness and hypnosis (MM-HYP), or hypnosis alone (control). There was a large non-significant time x condition effect for sleep disturbance (p=0.17; η2p = 0.15). There was a large significant time effect for the NF-HYP condition which was maintained at the 1-month reassessment, and there was a large non-significant time effect for the MM-HYP condition which was not maintained at the 1-month reassessment.

Lynning et al.’s52 study implemented trauma releasing exercise training and found a significant increase in participants sleep quality based on daily self-report measure over the course of the nine-week intervention. Becker et al.47 reported a significant improvement in PROMIS sleep disturbance scores from before to after acupuncture and health promotion education.

Quality Assessment

The details of the quality appraisal analyses are reported in Table 3. The quality score for the twelve RCTs ranged from 35-73%, the seven pilot RCTs ranged from 31-54%, the two quasi-experimental studies were 50% and 88%, and the eleven pre-post single group design studies ranged from 27-64%. The quality score for the two case reports were 50% and 88%, and the two qualitative studies were 70% and 80%. The quality score for the one case series was 81%.

View this table:
Table 3.

Quality appraisal.

Discussion

This is the first study to systematically review behavioral interventions to improve sleep in people with MS. The variability in the intervention types, intervention dose, outcomes used, training/expertise of interventionist, specific sample included, and quality of the study made it difficult to compare and synthesize results. Overall, the CBT-I, CBT/psychotherapy, and education/self-management support intervention studies reported positive outcomes, and the physical activity, mindfulness/relaxation, and complementary and alternative intervention studies reported mixed results. The quality appraisal scores ranged from low to high quality indicating potential for bias. While results of this systematic review suggest that many of the interventions are feasible and have a positive impact on sleep in people with MS, further research is necessary to demonstrate efficacy of most of the interventions. More attention to tailoring the intervention to the specific sleep issue, intervention dose, consensus on sleep outcome measures, adequate statistical power, including an appropriate comparison group, ensuring adequate training and experience of interventionists and ensuring intervention fidelity, and appropriate blinding is needed in future research.

Only nine out of 37 studies (24%) explicitly stated sleep was a primary outcome. Depression, fatigue, and feasibility were often named as the primary outcomes. This illustrates the lack of behavioral interventions designed to specifically target sleep in people with MS. What may have contributed to the lack of sleep as a primary outcome is that many of the interventions themselves were not designed to target sleep specifically. CBT-I which is a multidimension intervention to specifically treat insomnia was the exception, which likely explains the consensus in improved sleep outcomes in people with MS of the included CBT-I studies. CBT-I, which is a multicomponent treatment strategy that addresses behaviors and thoughts that can negatively impact sleep is the recommended first-line treatment of insomnia.70,71 The other interventions included in this review such as mindfulness, relaxation, and complementary and alternative interventions are less likely to target specific sleep impairments or disturbances but instead target secondary contributors to sleep.

It was interesting that the physical activity intervention studies had mixed results (eight had positive results, three had positive results although not statistically significant, and two had minimal to no change in sleep outcomes) due to extensive studies showing physical activity has a positive impact on various sleep outcomes in the general populations.72-76 There are several possible explanations for why physical activity had mixed results on sleep outcomes in people with MS including the studies were underpowered to detect meaningful change, the intervention lacked sufficient dose of physical activity to positively affect sleep, sleep impairment was not a requirement for eligibility, or a larger percentage of individuals with more progressive disability were included in the sample. While the exact mechanisms for how physical activity improves sleep are not clear, one possible mechanism is the rise in body temperature due to physical activity leads to self-induced internal cooling processes that initiate sleep.76,77 Perhaps due to heat sensitivity in people with MS, the rise in body temperature does not trigger the same internal cooling processes or perhaps other MS symptoms (such as spasticity or pain) mediate the impact on sleep. Additional research is needed to elucidate if physical activity does indeed have a positive impact on sleep outcomes, and if not, then why.

Another challenge with synthesizing the results is the outcomes used to assess sleep were often not valid or reliable measurements of sleep. For example, the primary construct assessed by the NeuroQoL and the Hamilton Depression Rating Scale are not sleep but rather a construct that is associated with sleep; however, these assessments appeared multiple times throughout the review as some studies’ sole sleep outcome measure. Also, interestingly, only six (16%) of the included studies used an objective measure of sleep such as actigraphy or EEG, and no study utilized polysomnography. While objective measures reduce potential bias and assess certain constructs of sleep, they are typically more time consuming and more costly. Perhaps because of the number of preliminary studies or studies with sleep as a secondary outcome or their ease of administration, many studies included in this systematic review utilized self-report sleep assessments. Because objective and self-report sleep measures assess different sleep constructs,78 both types of measures should be considered to aid in understanding the effects of behavioral interventions on sleep. Moving forward, studies to assess the impact of behavioral interventions on sleep should use valid and reliable measurements of sleep that are specific to the intended sleep outcome, such as the PSQI to assess self-report sleep quality, the ISI to assess insomnia severity, actigraphy to objectively assess sleep/wake cycle, and polysomnography to assess sleep stages.

Most studies (78%) assessed immediate change in sleep due to the intervention, and only nine studies26,28-30,40,49,53,54 included longer-term follow-up (range: one month26,40 to seven-nine months54). Importantly, three of the studies demonstrated sleep improvements immediately post intervention but were not maintained at long-term follow-up.28,40,53 Also, one study did not show positive improvement on sleep at the post-intervention or 3-month follow-up, but did show improvement on sleep at the 6-month follow-up.29 This illustrates the importance of including longer-term follow-ups to determine maintenance (or lack thereof) in improvement in sleep outcomes (suggesting maintenance of changed behavior) or that the impact of the intervention on sleep may take time to become apparent. Future studies should include delayed reassessments to determine maintenance of improvement or evolution of change in sleep. In addition, because half of the studies that demonstrated initial improvement in sleep failed to maintain improvement as reassessment, future research should consider emphasizing behavior change theories and techniques.

The quality appraisal that was completed as part of this systematic review highlights limitations and potential biases of the studies included in this review. Many of the studies lacked blinding for participants, interventionists, and/or outcome assessors. Also, many of the RCTs did not include a power analysis and the sample sizes were often small which limits the interpretation of the results. There were numerous participants who dropped out of several studies, and an analysis of the impact of attrition was often absent. These findings from the quality appraisal reveal the potential for bias in the articles included and thus conclusions and interpretation of the results should be viewed with this in mind.

We acknowledge that the JBI critical appraisal checklist for RCTs was used to assess the quality of the self-identified pilot RCTs which likely resulted in a lower quality score for the pilot RCTs. The systematic review team made this decision after thoughtful discussion and after being unable to locate a critical appraisal checklist specifically for pilot RCTs. Pilot RCTs are used to determine feasibility or effect size, while RCTs are used to determine efficacy or effectiveness, and there is debate to whether pilot studies should assess treatment effects or group differences.79 There is a need for a critical appraisal checklist specific for pilot RCTs, and the determination of “pilot” should be made a priori and in accordance with the purpose and design of the study trial. Another note on the importance of language precision is there was often lack of clarity if the reported MS disease duration was from diagnosis of MS or from symptom onset. This is an important distinction as it can be years from symptoms onset to actual physician diagnosis of MS.

Conclusion

Overall, this systematic review has summarized the current state of the literature on behavioral interventions for sleep in individuals with MS and suggests that additional well-designed research with the specific intention of assessing the impact of behavioral interventions on sleep using valid and reliable sleep measures in people with MS is warranted. The conclusions in this review and future research identified from this review will aid in guiding clinical practice centered around improving sleep in people with MS.

Data Availability

All data produced in the present study are available upon reasonable request to the authors

Acknowledgement

The results of this systematic review will be presented at ACRM 2022

Footnotes

  • Disclosures: David Turkowitch: None

    Sarah J. Donkers: None

    Silvana L. Costa: None

    Prasanna Vaduvathiriyan: None

    Joy Williams: None

    Catherine Siengsukon: owner and CEO of Sleep Health Education, LLC

Abbreviations

CBT
cognitive behavioral therapy
CBT-I
cognitive behavioral therapy for insomnia
ESS
Epworth Sleepiness Scale; International Restless Legs Syndrome Study Group Scale
ISI
Insomnia Severity Index
JBI
Joanna Briggs Institute
MS
multiple sclerosis
NeuroQoL
Quality of Life in Neurological Conditions
PRISMA
Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PROMIS
Patient-Reported Outcomes Measurement and Information System
PROSPERO
Prospective Register of Systematic Reviewers
PSQI
Pittsburg Sleep Quality Index
RCT
randomized controlled trial(s);
RLS
restless legs syndrome
SCL-90
Symptom Checklist-90
WASO
wake after sleep onset

References

  1. 1.↵
    Nelson LM, Wallin MT, Marrie RA, et al. A new way to estimate neurologic disease prevalence in the United States: Illustrated with MS. Neurology. 2019;92(10):469–480.
    OpenUrl
  2. 2.
    Culpepper WJ, Marrie RA, Langer-Gould A, et al. Validation of an algorithm for identifying MS cases in administrative health claims datasets. Neurology. 2019;92(10):e1016–e1028.
    OpenUrl
  3. 3.↵
    Wallin MT, Culpepper WJ, Campbell JD, et al. The prevalence of MS in the United States: A population-based estimate using health claims data. Neurology. 2019;92(10):e1029–e1040.
    OpenUrlCrossRefPubMed
  4. 4.↵
    Siengsukon CF, Alshehri M, Aldughmi M. Self-report sleep quality combined with sleep time variability distinguishes differences in fatigue, anxiety, and depression in individuals with multiple sclerosis: A secondary analysis. Mult Scler J Exp Transl Clin. 2018;4(4):2055217318815924.
    OpenUrl
  5. 5.↵
    Tachibana N, Howard RS, Hirsch NP, Miller DH, Moseley IF, Fish D. Sleep problems in multiple sclerosis. Eur Neurol. 1994;34(6):320–323.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    Braley TJ, Chervin RD. A practical approach to the diagnosis and management of sleep disorders in patients with multiple sclerosis. Ther Adv Neurol Disord. 2015;8(6):294–310.
    OpenUrlCrossRef
  7. 7.↵
    Brass SD, Li CS, Auerbach S. The underdiagnosis of sleep disorders in patients with multiple sclerosis. J Clin Sleep Med. 2014;10(9):1025–1031.
    OpenUrlPubMed
  8. 8.↵
    Boe Lunde HM, Aae TF, Indrevag W, et al. Poor sleep in patients with multiple sclerosis. PLoS One. 2012;7(11):e49996.
    OpenUrlCrossRefPubMed
  9. 9.↵
    Braley TJ. Overview: A Framework for the Discussion of Sleep in Multiple Sclerosis. Curr Sleep Med Rep. 2017;3(4):263–271.
    OpenUrl
  10. 10.↵
    Spoormaker VI, van den Bout J. Depression and anxiety complaints; relations with sleep disturbances. Eur Psychiatry. 2005;20(3):243–245.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    Melamud L, Golan D, Luboshitzky R, Lavi I, Miller A. Melatonin dysregulation, sleep disturbances and fatigue in multiple sclerosis. J Neurol Sci. 2012;314(1-2):37–40.
    OpenUrlPubMed
  12. 12.↵
    Soorensen KV, Alslev T, Christensen SE, Jensen NB, Orskov H. CSF somatostatin in multiple sclerosis: reversible loss of diurnal oscillation in relapses. Neurology. 1987;37(6):1050–1053.
    OpenUrl
  13. 13.↵
    Stanton BR, Barnes F, Silber E. Sleep and fatigue in multiple sclerosis. Mult Scler. 2006;12(4):481–486.
    OpenUrlCrossRefPubMedWeb of Science
  14. 14.
    Braley TJ, Kratz AL, Kaplish N, Chervin RD. Sleep and Cognitive Function in Multiple Sclerosis. Sleep. 2016;39(8):1525–1533.
    OpenUrlCrossRefPubMed
  15. 15.
    Clark CM, Fleming JA, Li D, Oger J, Klonoff H, Paty D. Sleep disturbance, depression, and lesion site in patients with multiple sclerosis. Arch Neurol. 1992;49(6):641–643.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.
    Hughes AJ, Turner AP, Alschuler KN, et al. Association Between Sleep Problems and Perceived Cognitive Dysfunction Over 12 Months in Individuals with Multiple Sclerosis. Behav Sleep Med. 2018;16(1):79–91.
    OpenUrl
  17. 17.
    Merlino G, Fratticci L, Lenchig C, et al. Prevalence of ‘poor sleep’ among patients with multiple sclerosis: an independent predictor of mental and physical status. Sleep Med. 2009;10(1):26–34.
    OpenUrlCrossRefPubMedWeb of Science
  18. 18.↵
    Siengsukon CF, Aldughmi M, Kahya M, et al. Individuals with mild MS with poor sleep quality have impaired visuospatial memory and lower perceived functional abilities. Disabil Health J. 2018;11(1):116–121.
    OpenUrl
  19. 19.↵
    Fitzgerald T, Vietri J. Residual Effects of Sleep Medications Are Commonly Reported and Associated with Impaired Patient-Reported Outcomes among Insomnia Patients in the United States. Sleep Disord. 2015;2015:607148.
    OpenUrl
  20. 20.
    Mendelson WB, Roth T, Cassella J, et al. The treatment of chronic insomnia: drug indications, chronic use and abuse liability. Summary of a 2001 New Clinical Drug Evaluation Unit meeting symposium. Sleep Med Rev. 2004;8(1):7–17.
    OpenUrlCrossRefPubMed
  21. 21.↵
    Miller P, Soundy A. The pharmacological and non-pharmacological interventions for the management of fatigue related multiple sclerosis. J Neurol Sci. 2017;381:41–54.
    OpenUrlPubMed
  22. 22.↵
    Motl RW, Sandroff BM, Kwakkel G, et al. Exercise in patients with multiple sclerosis. Lancet Neurol. 2017;16(10):848–856.
    OpenUrlPubMed
  23. 23.↵
    National Heart L, and Blood Institute. Study quality assessment tools. https://www.nhlbi.nih.gov/health-topics/study-quality-assessment-tools. xUpdated July 2021. Accessed June 8, 2022.
  24. 24.↵
    Institute. JB. Critical appraisal tools. https://jbi.global/critical-appraisal-tools. Published 2020. Accessed March 24, 2022.
  25. 25.↵
    Lewis J, Mackenzie L. Cognitive changes after breast cancer: a scoping review to identify problems encountered by women when returning to work. Disabil Rehabil. 2021:1–19.
  26. 26.↵
    Abbasi SM, Alimohammadi NP, Pahlavanzadeh SM. Effectiveness of Cognitive Behavioral Therapy on the Quality of Sleep in Women with Multiple Sclerosis: A Randomized Controlled Trial Study. Int J Community Based Nurs Midwifery. 2016;4(4):320–328.
    OpenUrl
  27. 27.↵
    Baron KG, Corden M, Jin L, Mohr DC. Impact of psychotherapy on insomnia symptoms in patients with depression and multiple sclerosis. J Behav Med. 2011;34(2):92–101.
    OpenUrlCrossRefPubMed
  28. 28.↵
    Cavalera C, Rovaris M, Mendozzi L, et al. Online meditation training for people with multiple sclerosis: A randomized controlled trial. Mult Scler. 2019;25(4):610–617.
    OpenUrl
  29. 29.↵
    Hugos CL, Chen Z, Chen Y, et al. A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Short- and medium-term benefits. Mult Scler. 2019;25(2):275–285.
    OpenUrl
  30. 30.↵
    Kiropoulos LA, Kilpatrick T, Holmes A, Threader J. A pilot randomized controlled trial of a tailored cognitive behavioural therapy based intervention for depressive symptoms in those newly diagnosed with multiple sclerosis. BMC Psychiatry. 2016;16(1):435.
    OpenUrl
  31. 31.↵
    Pilutti LA, Dlugonski D, Sandroff BM, Klaren R, Motl RW. Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis. Mult Scler. 2014;20(5):594–601.
    OpenUrlCrossRefPubMed
  32. 32.↵
    Sadeghi Bahmani D, Razazian N, Farnia V, Alikhani M, Tatari F, Brand S. Compared to an active control condition, in persons with multiple sclerosis two different types of exercise training improved sleep and depression, but not fatigue, paresthesia, and intolerance of uncertainty. Mult Scler Relat Disord. 2019;36:101356.
    OpenUrl
  33. 33.↵
    Sadeghi Bahmani D, Motl RW, Razazian N, Khazaie H, Brand S. Aquatic exercising may improve sexual function in females with multiple sclerosis - an exploratory study. Mult Scler Relat Disord. 2020;43:102106.
    OpenUrl
  34. 34.↵
    Sgoifo A, Bignamini A, La Mantia L, et al. Integrated Imaginative Distention Therapy to Cope with Fatigue. DIMMI SI Study: The First Randomized Controlled Trial in Multiple Sclerosis. Neurol Ther. 2017;6(2):213–223.
    OpenUrl
  35. 35.↵
    Sajadi M, Davodabady F, Ebrahimi-Monfared M. The effect of foot reflexology on fatigue, sleep quality and anxiety in patients with multiple sclerosis: A randomized controlled trial. Archives of Neuroscience. 2020;7(3):1–8.
    OpenUrl
  36. 36.↵
    Akbarfahimi M, Nabavi SM, Kor B, Rezaie L, Paschall E. The Effectiveness of Occupational Therapy-Based Sleep Interventions on Quality of Life and Fatigue in Patients with Multiple Sclerosis: A Pilot Randomized Clinical Trial Study. Neuropsychiatr Dis Treat. 2020;16:1369–1379.
    OpenUrl
  37. 37.↵
    Al-Sharman A, Khalil H, El-Salem K, Aldughmi M, Aburub A. The effects of aerobic exercise on sleep quality measures and sleep-related biomarkers in individuals with Multiple Sclerosis: A pilot randomised controlled trial. NeuroRehabilitation. 2019;45(1):107–115.
    OpenUrl
  38. 38.↵
    Cederberg KLJ, Motl RW. Feasibility and efficacy of a physical activity intervention for managing restless legs syndrome in multiple sclerosis: Results of a pilot randomized controlled trial. Mult Scler Relat Disord. 2021;50:102836.
    OpenUrl
  39. 39.↵
    Grubić Kezele T, Trope Z, Ahel V, et al. Upper-lower limb and breathing exercise program for improving sleep quality and psychological status in multiple sclerosis: A pilot randomized controlled trial. Brain Impairment. 2021.
  40. 40.↵
    Jensen MP, Battalio SL, Chan JF, et al. USE OF NEUROFEEDBACK AND MINDFULNESS TO ENHANCE RESPONSE TO HYPNOSIS TREATMENT IN INDIVIDUALS WITH MULTIPLE SCLEROSIS: Results From a Pilot Randomized Clinical Trial. Int J Clin Exp Hypn. 2018;66(3):231–264.
    OpenUrl
  41. 41.↵
    Siengsukon CF, Aldughmi M, Kahya M, et al. Randomized controlled trial of exercise interventions to improve sleep quality and daytime sleepiness in individuals with multiple sclerosis: A pilot study. Mult Scler J Exp Transl Clin. 2016;2:2055217316680639.
    OpenUrl
  42. 42.↵
    Siengsukon CF, Alshehri M, Williams C, Drerup M, Lynch S. Feasibility and treatment effect of cognitive behavioral therapy for insomnia in individuals with multiple sclerosis: A pilot randomized controlled trial. Mult Scler Relat Disord. 2020;40:101958.
    OpenUrlPubMed
  43. 43.↵
    Williams-Cooke C, LeSuer L, Drerup M, Siengsukon C. The Impact of Cognitive Behavioral Therapy for Insomnia on Sleep Log and Actigraphy Outcomes in People with Multiple Sclerosis: A Secondary Analysis. Nat Sci Sleep. 2021;13:1865–1874.
    OpenUrl
  44. 44.↵
    Siengsukon CF, Beck ES, Jr.., Drerup M. Feasibility and Treatment Effect of a Web-Based Cognitive Behavioral Therapy for Insomnia Program in Individuals with Multiple Sclerosis: A Pilot Randomized Controlled Trial. Int J MS Care. 2021;23(3):107–113.
    OpenUrl
  45. 45.↵
    Bahmani DS, Kesselring J, Papadimitriou M, et al. In Patients With Multiple Sclerosis, Both Objective and Subjective Sleep, Depression, Fatigue, and Paresthesia Improved After 3 Weeks of Regular Exercise. Frontiers in Psychiatry. 2019;10.
  46. 46.↵
    Andreu-Caravaca L, Ramos-Campo DJ, Abellan-Aynes O, et al. 10-Weeks of resistance training improves sleep quality and cardiac autonomic control in persons with multiple sclerosis. Disabil Rehabil. 2021:1–9.
  47. 47.↵
    Becker H, Stuifbergen AK, Schnyer RN, Morrison JD, Henneghan A. Integrating Acupuncture Within a Wellness Intervention for Women With Multiple Sclerosis. Journal of Holistic Nursing. 2017;35(1):86–96.
    OpenUrl
  48. 48.↵
    Dayapoglu N, Tan M. Evaluation of the effect of progressive relaxation exercises on fatigue and sleep quality in patients with multiple sclerosis. J Altern Complement Med. 2012;18(10):983–987.
    OpenUrlCrossRefPubMed
  49. 49.↵
    Hoogerwerf AEW, Bol Y, Lobbestael J, Hupperts R, van Heugten CM. Mindfulness-based cognitive therapy for severely fatigued multiple sclerosis patients: A waiting list controlled study. J Rehabil Med. 2017;49(6):497–504.
    OpenUrl
  50. 50.↵
    Jeong IC, Karpatkin H, Stein J, Finkelstein J. Relationship Between Exercise Duration in Multimodal Telerehabilitation and Quality of Sleep in Patients with Multiple Sclerosis. Stud Health Technol Inform. 2020;270:658–662.
    OpenUrl
  51. 51.↵
    Kozlowski AJ, Fabian M, Lad D, Delgado AD. Feasibility and Safety of a Powered Exoskeleton for Assisted Walking for Persons With Multiple Sclerosis: A Single-Group Preliminary Study. Arch Phys Med Rehabil. 2017;98(7):1300–1307.
    OpenUrl
  52. 52.↵
    Lynning M, Svane C, Westergaard K, Bergien SO, Gunnersen SR, Skovgaard L. Tension and trauma releasing exercises for people with multiple sclerosis - An exploratory pilot study. J Tradit Complement Med. 2021;11(5):383–389.
    OpenUrl
  53. 53.↵
    Mehrabani G, Aminian S, Norton S, Motl RW, Manns PJ. Preliminary efficacy of the “SitLess with MS” intervention for changing sedentary behaviour, symptoms, and physical performance in multiple sclerosis. Disabil Rehabil. 2021:1–8.
  54. 54.↵
    Sauter C, Zebenholzer K, Hisakawa J, Zeitlhofer J, Vass K. A longitudinal study on effects of a six-week course for energy conservation for multiple sclerosis patients. Mult Scler. 2008;14(4):500–505.
    OpenUrlCrossRefPubMedWeb of Science
  55. 55.↵
    Vasudevan S, Devulapally S, Chirravuri K, Elangovan V, Kesavan N. Personalized Yoga Therapy for Multiple Sclerosis: Effect on Symptom Management and Quality of Life. Int J Yoga Therap. 2021;31(1).
  56. 56.↵
    Loveless JP, Russo JM, Andersen VC. The Successful Treatment of Insomnia in a Patient With a Complex Neurological History. Clinical Case Studies. 2020;19(2):101–114.
    OpenUrl
  57. 57.↵
    Majendie CMA, Dysch L, Carrigan N. Cognitive Behavioral Therapy for Insomnia (CBT-I) for an Adult with Multiple Sclerosis. Clinical Case Studies. 2017;16(2):115–131.
    OpenUrl
  58. 58.↵
    Simpson R, Byrne S, Wood K, Mair FS, Mercer SW. Optimising mindfulness-based stress reduction for people with multiple sclerosis. Chronic Illn. 2018;14(2):154–166.
    OpenUrl
  59. 59.↵
    Sessanna L, Nisbet P, Alanazi N, et al. The Experience of Participating in an 8-Week Mindfulness Based Stress Reduction plus Sleep Retraining Course among Women Living with Multiple Sclerosis. Clin Nurs Res. 2021;30(5):558–566.
    OpenUrl
  60. 60.↵
    Lorenz RA, Auerbach S, Nisbet P, et al. Improving Sleep among Adults with Multiple Sclerosis using Mindfulness plus Sleep Education. West J Nurs Res. 2021;43(3):273–283.
    OpenUrl
  61. 61.↵
    Munger KC, Martinez AP, Hyland MH. The impact of cognitive rehabilitation on quality of life in multiple sclerosis: A pilot study. Mult Scler J Exp Transl Clin. 2021;7(3):20552173211040239.
    OpenUrl
  62. 62.↵
    Clancy M, Drerup M, Sullivan AB. Outcomes of Cognitive-Behavioral Treatment for Insomnia on Insomnia, Depression, and Fatigue for Individuals with Multiple Sclerosis: A Case Series. Int J MS Care. 2015;17(6):261–267.
    OpenUrlCrossRefPubMed
  63. 63.↵
    Williams-Cooke C, LeSuer L, Drerup M, Siengsukon C. The Impact of Cognitive Behavioral Therapy for Insomnia on Sleep Log and Actigraphy Outcomes in People with Multiple Sclerosis: A Secondary Analysis. Nature & Science of Sleep. 2021;13:1865–1874.
    OpenUrl
  64. 64.↵
    Jensen MP, Battalio SL, Chan J, et al. Use of neurofeedback and mindfulness to enhance response to hypnosis treatment in individuals with multiple sclerosis. BMC Complementary and Alternative Medicine. 2017;17.
  65. 65.↵
    Sadeghi Bahmani D, Razazian N, Farnia V, Alikhani M, Tatari F, Brand S. Compared to an active control condition, in persons with multiple sclerosis two different types of exercise training improved sleep and depression, but not fatigue, paresthesia, and intolerance of uncertainty. Multiple Sclerosis and Related Disorders. 2019;36:101356.
    OpenUrl
  66. 66.↵
    Mohr DC, Hart SL, Julian L, et al. Telephone-administered psychotherapy for depression. Arch Gen Psychiatry. 2005;62(9):1007–1014.
    OpenUrlCrossRefPubMedWeb of Science
  67. 67.↵
    Cavalera C, Pagnini F, Rovaris M, et al. A telemedicine meditation intervention for people with multiple sclerosis and their caregivers: study protocol for a randomized controlled trial. Trials. 2016;17:4.
    OpenUrl
  68. 68.↵
    Simpson R, Mair FS, Mercer SW. Mindfulness-based stress reduction for people with multiple sclerosis - a feasibility randomised controlled trial. BMC Neurol. 2017;17(1):94.
    OpenUrl
  69. 69.↵
    Sajadi M, Davodabady F, Ebrahimi-Monfared M. The Effect of Foot Reflexology on Fatigue, Sleep Quality and Anxiety in Patients with Multiple Sclerosis: A Randomized Controlled Trial. Archives of Neuroscience. 2020;7(3).
  70. 70.↵
    Wu JQ, Appleman ER, Salazar RD, Ong JC. Cognitive Behavioral Therapy for Insomnia Comorbid With Psychiatric and Medical Conditions: A Meta-analysis. JAMA Intern Med. 2015;175(9):1461–1472.
    OpenUrl
  71. 71.↵
    Geiger-Brown JM, Rogers VE, Liu W, Ludeman EM, Downton KD, Diaz-Abad M. Cognitive behavioral therapy in persons with comorbid insomnia: A meta-analysis. Sleep Med Rev. 2015;23:54–67.
    OpenUrlCrossRefPubMed
  72. 72.↵
    Vanderlinden J, Boen F, van Uffelen JGZ. Effects of physical activity programs on sleep outcomes in older adults: a systematic review. Int J Behav Nutr Phys Act. 2020;17(1):11.
    OpenUrlPubMed
  73. 73.
    Kovacevic A, Mavros Y, Heisz JJ, Fiatarone Singh MA. The effect of resistance exercise on sleep: A systematic review of randomized controlled trials. Sleep Med Rev. 2018;39:52–68.
    OpenUrlCrossRefPubMed
  74. 74.
    Kelley GA, Kelley KS. Exercise and sleep: a systematic review of previous meta-analyses. J Evid Based Med. 2017;10(1):26–36.
    OpenUrlPubMed
  75. 75.
    Kubitz KA, Landers DM, Petruzzello SJ, Han M. The effects of acute and chronic exercise on sleep. A meta-analytic review. Sports Med. 1996;21(4):277–291.
    OpenUrlCrossRefPubMedWeb of Science
  76. 76.↵
    Driver HS, Taylor SR. Exercise and sleep. Sleep Med Rev. 2000;4(4):387–402.
    OpenUrlCrossRefPubMedWeb of Science
  77. 77.↵
    Buman MP, Hekler EB, Bliwise DL, King AC. Moderators and mediators of exercise-induced objective sleep improvements in midlife and older adults with sleep complaints. Health Psychol. 2011;30(5):579–587.
    OpenUrlCrossRefPubMedWeb of Science
  78. 78.↵
    Bernstein JPK, DeVito A, Calamia M. Subjectively and Objectively Measured Sleep Predict Differing Aspects of Cognitive Functioning in Adults. Arch Clin Neuropsychol. 2019;34(7):1127–1137.
    OpenUrl
  79. 79.↵
    Abbott JH. The distinction between randomized clinical trials (RCTs) and preliminary feasibility and pilot studies: what they are and are not. J Orthop Sports Phys Ther. 2014;44(8):555–558.
    OpenUrlCrossRefPubMed
Back to top
Posted October 30, 2022.
Download PDF

Supplementary Material

Data/Code
Email
Behavioral interventions to improve sleep outcomes in people with multiple sclerosis: A systematic review
David Turkowitch, Sarah J. Donkers, Silvana L. Costa, Prasanna Vaduvathiriyan, Joy Williams, Catherine Siengsukon
medRxiv 2022.10.29.22281670; doi: https://doi.org/10.1101/2022.10.29.22281670
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area